Brooks Laboratories Limited (BROOKS.NS)
INR 156.86
(2.0%)
INR 156.86
(2.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -103.75 Million | -144.9 Million | -374.4 Million | 44.58 Million | -93.88 Million | -50.49 Million |
| Net Income | -195.91 Million | -354.25 Million | -238.97 Million | -89.93 Million | -135.13 Million | -149.47 Million |
| Depreciation & Amortization | 17.73 Million | 70.26 Million | 73.5 Million | 71.43 Million | 66.47 Million | 64.99 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -130.71 Million | 114.36 Million | -243.13 Million | 73.66 Million | -76.16 Million | 12.2 Million |
| Other non-cash items | 336.42 Million | 24.7 Million | 34.19 Million | -10.57 Million | 50.94 Million | 21.78 Million |
| Investing Cash Flow | 807 Thousand | 4.94 Million | -249.08 Million | -51.29 Million | -23.25 Million | 11.15 Million |
| Investments in PPE | -4.39 Million | -4.67 Million | -276.12 Million | -56.13 Million | -25.83 Million | -8.67 Million |
| Acquisitions | - | 176.29 Million | 773.28 Million | - | 4.3 Million | 15.3 Million |
| Investment purchases | - | -184.95 Million | -2.97 Million | - | -3.12 Million | -18.75 Million |
| Sales/Maturities of investments | 5.19 Million | 8.66 Million | -773.28 Million | 3.11 Million | -1.17 Million | 3.45 Million |
| Other Investing Activities | 6.21 Million | 9.62 Million | 30 Million | 1.72 Million | 2.57 Million | 19.82 Million |
| Financing Cash Flow | 103.96 Million | 114.14 Million | 640.7 Million | 11.58 Million | 96.12 Million | 57.83 Million |
| Debt repayment | -6.21 Million | -38.35 Million | -71.72 Million | -43.81 Million | -42.59 Million | -32.81 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 112.67 Million | - | - | - | 175.47 Million | 55.54 Million |
| Other Financing Activities | 104.71 Million | 152.49 Million | 712.42 Million | 55.4 Million | -36.75 Million | 35.09 Million |
| Accounts receivables | -33.83 Million | -26.87 Million | -50.05 Million | 19.94 Million | -44.77 Million | -18.59 Million |
| Accounts payables | -78.89 Million | 108.37 Million | -27 Million | 47.37 Million | -10.73 Million | 4.98 Million |
| Inventory | 16.92 Million | 32.86 Million | -39.19 Million | -98.28 Million | -37.21 Million | 13.55 Million |
| Other working capital | -34.91 Million | 1000.00 | -126.87 Million | 104.62 Million | 16.55 Million | 12.25 Million |
| Cash at beginning of period | 232 Thousand | 26.05 Million | 8.83 Million | 3.95 Million | 24.98 Million | 6.45 Million |
| Cash at end of period | 6.93 Million | 232 Thousand | 26.05 Million | 8.83 Million | 3.96 Million | 24.93 Million |
| Capital Expenditure | -4.39 Million | -4.67 Million | -276.12 Million | -56.13 Million | -25.83 Million | -8.67 Million |
| Effect of forex changes on cash | - | 1000.00 | -2000.00 | -1000.00 | -1000.00 | 45 Thousand |
| Net cash flow / Change in cash | 6.7 Million | -25.81 Million | 17.21 Million | 4.88 Million | -21.02 Million | 18.48 Million |
| Free Cash Flow | -108.14 Million | -149.58 Million | -650.53 Million | -11.55 Million | -119.72 Million | -59.16 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.13 Million | -195.91 Million | -96.05 Million | -38.78 Million | -16.37 Million | -44.7 Million |
| Depreciation & Amortization | - | 17.73 Million | - | 4.34 Million | 8.82 Million | 4.4 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -130.71 Million | - | - | -20.29 Million | - |
| Other non-cash items | 24.13 Million | 336.42 Million | 96.05 Million | 38.78 Million | 16.37 Million | 44.7 Million |
| Investing Cash Flow | - | 807 Thousand | - | - | 7.43 Million | - |
| Investments in PPE | - | -4.39 Million | - | - | -821 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 5.19 Million | - | - | - | - |
| Other Investing Activities | - | 6.21 Million | - | - | 8.25 Million | - |
| Financing Cash Flow | - | 103.96 Million | - | - | 86.09 Million | - |
| Debt repayment | - | -6.21 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 112.67 Million | - | - | - | - |
| Other Financing Activities | - | 104.71 Million | - | - | 86.09 Million | - |
| Accounts receivables | - | -33.83 Million | - | - | -30.92 Million | - |
| Accounts payables | - | -78.89 Million | - | - | - | - |
| Inventory | - | 16.92 Million | - | - | 10.63 Million | - |
| Other working capital | - | -34.91 Million | - | - | - | - |
| Cash at beginning of period | - | 232 Thousand | - | 5.03 Million | 3.05 Million | 232 Thousand |
| Cash at end of period | - | 6.93 Million | - | 13.72 Million | 1.97 Million | 9.05 Million |
| Capital Expenditure | - | -4.39 Million | - | - | -821 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | 232 Thousand | - |
| Net cash flow / Change in cash | - | 6.7 Million | - | 8.69 Million | -1.08 Million | 8.81 Million |
| Free Cash Flow | - | -108.14 Million | - | 8.69 Million | -92.6 Million | 8.81 Million |
RAKR
EE
RTWG
7327
EMCMF
ASTS